Estetrol Reduces Bone Turnover Markers in Postmenopausal Women
CHICAGO — The levels of two bone turnover markers were significantly lower at 3 months and 1 year in postmenopausal ...
Month: October 2024
NCCRT Wins in ESCC Trial
SAN DIEGO — Neoadjuvant concurrent chemoradiotherapy significantly improves survival outcomes over adjuvant sequential chemoradiotherapy (ASCRT) in patients with locally advanced ...
IMRT vs Proton Therapy for Early Prostate Cancer?
For patients with intermediate- or low-risk localized prostate cancer, intensity-modulated radiation therapy (IMRT) and proton beam therapy are both safe and ...
COVID-19 Raises Hypertension and Kidney Disease Risk in T1D
TOPLINE:For patients with type 1 diabetes (T1D), a positive test or hospitalization for COVID-19 increases the risk of developing hypertension, ...
Race Adjustments in Algorithms Boost CRC Risk Prediction
TOPLINE:Accounting for racial disparities, including in the quality of family history data, enhanced the predictive performance of a colorectal cancer ...
Altered Antibody Predicts Crohn’s Years Before Diagnosis
TOPLINE:A unique glycosylation signature on circulating antibodies is detectable in blood up to 6 years before a diagnosis of Crohn's ...
Heat-Related Pediatric ED Visits More Than Double
ORLANDO — Heat-related emergency department visits in children and teens more than doubled over the past decade in two Texas ...
FDA Approves Dupilumab as Add-On for COPD
The US Food and Drug Administration has approved dupilumab as an add-on maintenance therapy for adults whose chronic obstructive pulmonary ...
Delgocitinib Approved in Europe for Chronic Hand Eczema
The European Commission has approved the topical pan-JAK inhibitor delgocitinib for adults with moderate to severe hand eczema, for whom ...
Experts raise doubts about medical evidence presented in court
Cheshire PoliceSenior doctors and scientists have told the BBC they have concerns about how crucial evidence was presented to the ...
